⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 21, 2025Journal of Gastrointestinal OncologyOpen Access

A combination of MRI diffusion-derived vessel density (DDVD) and slow diffusion coefficient (SDC) can reliably diagnose liver hemangioma: a testing of three centers’ data

Genwen Hu Cai‐Ying Li Gonghao Ling Cun‐Jing Zheng Michael S Y Zhu Akmal Sabarudin Xiaohui Duan Xinming Li Jun Shen Yì Wáng

View Full Paper

Ask AI

Bookmark

Share

Abstract

When a combination of DDVDm and SDCm is used to evaluate the liver, HG and MFL can mostly be reliably separated without the need for a contrast-enhanced scan. Our results will be relevant for HG confirmation when MRI is the first-line examination for the liver.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hu et al. (2025) studied this question.

synapsesocial.com/papers/69de648fa051b8e25be93ed2 https://doi.org/10.21037/jgo-2025-424

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Identification and functional validation of SPON2 as a novel biomarker for the diagnosis and prognosis in hepatocellular carcinomaJournal of Gastrointestinal Oncology · Mon,
2Molecular characteristics and metastatic mechanism of patients diagnosed with Krukenberg tumor from gastric cancerJournal of Gastrointestinal Oncology · Wed,
3Brain metastasis from KRAS wild-type pancreatic cancer and organoid correlates: a case reportJournal of Gastrointestinal Oncology · Wed,
4Trends of mortality among patients with malignant neoplasms of digestive system in the United States from 2007 to 2021Journal of Gastrointestinal Oncology · Mon,
5Integrating nutritional and immune-inflammation-based index predicts disease-free survival of colorectal cancer patients undergoing radical surgeryJournal of Gastrointestinal Oncology · Wed,

More from Journal of Gastrointestinal Oncology

Adebrelimab combined with anlotinib plus hepatic arterial infusion chemotherapy or intravenous chemotherapy for first-line treatment of advanced biliary tract cancer: protocol for a randomized open-label clinical studyWed,
Effects of anlotinib combined with camrelizumab and chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma on tumor immune microenvironmentFri,
Global burden of gastric cancer attributed to high-salt diets: spatiotemporal trends and socio-demographic inequalities from 1990 to 2021Fri,
Local radiotherapy polarized tumor-associated macrophages enhance the efficacy of Claudin18.2-targeted CAR-T therapy in pancreatic cancerFri,
Colorectal cancer prognosis: insights from the tumor immune microenvironment and gut microbiotaFri,